GFM
EDIT icon

GF Fund Management’s Editas Medicine EDIT Stock Holding History

GF Fund Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.83K Buy
3,033
+859
+40% +$2.51K ﹤0.01% 539
2026
Q1 		$5.37K Buy
2,174
+263
+14% +$557 ﹤0.01% 603
2025
Q4 		$3.92K Sell
1,911
-24
-1% -$69 ﹤0.01% 630
2025
Q3 		$6.71K Sell
1,935
-178
-8% -$497 ﹤0.01% 588
2025
Q2 		$4.65K Hold
2,113
– – ﹤0.01% 632
2025
Q1 		$2.45K Buy
2,113
+283
+15% +$416 ﹤0.01% 645
2024
Q4 		$2.32K Buy
+1,830
New +$4.66K ﹤0.01% 634

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

GF Fund Management's EDIT Position: Q2 2026 in Review

GF Fund Management increased its Editas Medicine (EDIT) stake by 40% in Q2 2026, buying an estimated $2.51K and bringing the position to 3,033 shares worth $9.83K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

GF Fund Management first reported a position in EDIT in Q4 2024 and has held it in 7 quarters since. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • GF Fund Management held 3,033 shares of Editas Medicine worth $9.83K as of Q2 2026.
  • GF Fund Management bought 859 Editas Medicine shares in Q2 2026, an estimated $2.51K.
  • Editas Medicine made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #539 holding.
  • GF Fund Management first reported a position in Editas Medicine in Q4 2024 and has held it in 7 quarters since.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.